185564-12-9Relevant academic research and scientific papers
DNA Methyltransferase inhibitors
-
Page 15-16, (2008/06/13)
A compound of the formula or a pharmaceutically acceptable salt thereof,whereinR1, R2, and R3 are the same or different and are independently hydrogen, lower alkyl, aryl or substituted aryl, lower alkoxy, lower alkoxyalkyl, or cycloalkyl or cycloalkyl alkoxy, where each cycloalkyl group has from 3-7 members, where up to two of the cycloalkyl members are optionally hetero atoms selected from oxygen and nitrogen, and where any member of the alkyl, aryl or cycloalkyl group is optionally substituted with halogen, lower alkyl or lower alkoxy, aryl or substituted aryl, andwhereR3 can be ribose, deoxyribose or phosphorylated derivatives thereof,whereinR1, R2, and R3 are not all hydrogen andwhereinwhen R3 is ribose, deoxyribose or phosphorylated derivatives thereof, one of R1 or R2 is not hydrogen.
Synthesis, antibody conjugation, radiolabeling, and biodistribution of the first diethylene triamine pentahydroxamate (DTPH) bifunctional chelating agent
Safavy, A.,Smith, D. C.,Bazooband, A.,Buchsbaum, D. J.
, p. S738 - S740 (2007/10/03)
Synthesis of a novel penthahydroxamic acid bifunctional chelating agent (BCA) constructed on the diethylene triamine core of diethylene triamine pentaacetic acid (DTPA) is reported. Thus, the Nα, Nζ-[tetrakis((N-hydroxy-N-methyl)carb
